These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2443479)

  • 1. Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma.
    Kar P; Gandhi BM; Irshad M; Gupta H; Tandon BN
    J Assoc Physicians India; 1987 Apr; 35(4):288-9. PubMed ID: 2443479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Nov; 50(5):1682. PubMed ID: 19739256
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nonspecific tumor markers in hepatocellular carcinoma].
    Stanciu L; Dumitraşcu D; Radu D; Badea R; Petcovici M; Ioniţă A; Szabo P; Pascu O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(5):443-9. PubMed ID: 2473509
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-fetoprotein and hepatocellular carcinoma.
    Colli A; Fraquelli M; Conte D
    Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
    [No Abstract]   [Full Text] [Related]  

  • 7. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
    Wong CB; Attar BM; Shimoda SS
    Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
    [No Abstract]   [Full Text] [Related]  

  • 9. [Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma].
    Yamashiki M; Kosaka Y
    Rinsho Byori; 1989 Feb; 37(2):118-21. PubMed ID: 2471846
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biological markers of hepatocellular carcinoma].
    Arfaoui D; Elloumi H; Ajmi S
    Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The application of serum tumor markers in the diagnosis of hepatocellular carcinoma].
    Liao HY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):379-80. PubMed ID: 15918977
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of tumor markers in the diagnosis and follow-up of liver tumors].
    Ottó S
    Orv Hetil; 2004 Feb; 145(7 Suppl 1):385-7. PubMed ID: 15049057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are alpha-fetoprotein and other markers useful in the diagnosis and prognosis of hepatocellular carcinoma?].
    Forner A; Liccioni A; Reig ME
    Gastroenterol Hepatol; 2014 Jan; 37(1):17-20. PubMed ID: 24332662
    [No Abstract]   [Full Text] [Related]  

  • 14. Biomarkers for the early detection of cancer: an inflammatory concept.
    Roy HK; Khandekar JD
    Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
    [No Abstract]   [Full Text] [Related]  

  • 15. [Screening for hepatocellular carcinoma].
    Leone N; Rizzetto M
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
    Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G
    Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma].
    Aoyagi Y; Suda T; Kawai H; Tamura Y; Igarashi M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():665-9. PubMed ID: 20960847
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
    Riener MO; Stenner F; Liewen H; Hellerbrand C; Bahra M; Kristiansen G
    Hepatology; 2009 Jul; 50(1):326. PubMed ID: 19496179
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assay of decarboxy-prothrombin: its value in the diagnosis of hepatocellular carcinoma].
    Soulier JP; Lefrère JJ; Gozin D
    Ann Med Interne (Paris); 1988; 139(1):7-11. PubMed ID: 2834988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.